Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 4
2014 1
2018 1
2023 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Kelley RK, Ueno M, Yoo C, Finn RS, Furuse J, Ren Z, Yau T, Klümpen HJ, Chan SL, Ozaka M, Verslype C, Bouattour M, Park JO, Barajas O, Pelzer U, Valle JW, Yu L, Malhotra U, Siegel AB, Edeline J, Vogel A; KEYNOTE-966 Investigators. Kelley RK, et al. Lancet. 2023 Jun 3;401(10391):1853-1865. doi: 10.1016/S0140-6736(23)00727-4. Epub 2023 Apr 16. Lancet. 2023. PMID: 37075781 Free article. Clinical Trial.
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients.
Toledano-Fonseca M, Gómez-España MA, Élez E, Grávalos C, García-Alfonso P, Rodríguez R, Losa F, Alés Díaz I, Graña B, Valladares-Ayerbes M, García-Ortiz MV, Polo E, Salgado M, Rivera F, Safont MJ, Salud A, Ruiz-Casado A, Tabernero JM, Riesco MC, Rodríguez-Ariza A, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). Toledano-Fonseca M, et al. Among authors: ales diaz i. Biomed Pharmacother. 2023 Mar;159:114272. doi: 10.1016/j.biopha.2023.114272. Epub 2023 Jan 25. Biomed Pharmacother. 2023. PMID: 36706629 Free article.
Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study.
Carabante-Ocón F, Cobo-Dols M, Benavides-Orgaz M, Gil-Calle S, Alés-Díaz I, Bretón-García JJ, Villar-Chamorro E, Montesa-Pino A, Alcalde-García J, Gutiérrez-Calderón V. Carabante-Ocón F, et al. Among authors: ales diaz i. Clin Lung Cancer. 2005 Sep;7(2):121-6. doi: 10.3816/CLC.2005.n.027. Clin Lung Cancer. 2005. PMID: 16179099 Clinical Trial.
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.
Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A. Fernández A, et al. Among authors: ales diaz i. BMC Cancer. 2018 Nov 29;18(1):1185. doi: 10.1186/s12885-018-5101-3. BMC Cancer. 2018. PMID: 30497432 Free PMC article.
Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M, Villar Chamorro E, Alés Díaz I, Gil Calle S, Alcalde García J, Gutiérrez Calderón V, Carabantes Ocón F, Montesa Pino A, Bretón García JJ, Benavides Orgaz M. Cobo Dols M, et al. Among authors: ales diaz i. Clin Transl Oncol. 2006 Oct;8(10):742-9. doi: 10.1007/s12094-006-0121-x. Clin Transl Oncol. 2006. PMID: 17074673 Clinical Trial.
Cisplatin plus continuous infusion vinorelbine for the treatment of advanced non-small cell lung cancer: a phase I-II study.
Cobo-Dols M, Gil-Calle S, Villar-Chamorro E, Alés-Díaz I, Carabantes-Ocón F, Alcalde-García J, Gutiérrez-Calderón V, Montesa-Pino A, Bretón-García JJ, Benavides-Orgaz M. Cobo-Dols M, et al. Among authors: ales diaz i. Clin Transl Oncol. 2006 Jul;8(7):519-24. doi: 10.1007/s12094-006-0052-6. Clin Transl Oncol. 2006. PMID: 16870542 Clinical Trial.
Secondary signet-ring cell tumour of the prostate derived from a primary gastric malignancy.
Cobo Dols M, Muñoz Gallardo S, Peláez Angulo J, Algarra García R, Fuente Lupiáñez C, Gil Calle S, Villar Chamorro E, Montesa Pino A, Alcaide García J, Ales Díaz I, Gutiérrez Calderón V, Carabante Ocón F, Benavides Orgaz M. Cobo Dols M, et al. Among authors: ales diaz i. Clin Transl Oncol. 2005 Oct;7(9):409-12. doi: 10.1007/BF02716587. Clin Transl Oncol. 2005. PMID: 16238976